Neogen Corp
NEOG- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000711377
In the last 90 days, Neogen Corp insiders filed 1 open-market purchase and 0 sales; 316 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Members of Congress who traded NEOG
Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.
- Trades
- 2
- Filings
- 2
- Members
- 2
- Buys / sells
- 0 / 2
- Estimated volume
- $16.0K
- Sum of range midpoints
| Member | Trades | Buys / sells | Est. volume | Last traded | Last filed |
|---|---|---|---|---|---|
| Greg GianforteRepublican · House · MT | 1 | 0 / 1 | $8.00K | Oct 13, 2020 | Nov 9, 2020 |
| Donna E. ShalalaDemocrat · House · FL | 1 | 0 / 1 | $8.00K | Jun 24, 2019 | Apr 27, 2020 |
Trades
Every reported trade in Neogen Corp, newest filings first.
| Member | Asset | Type | Owner | Traded | Filed | Delay | Amount | Source |
|---|---|---|---|---|---|---|---|---|
| Greg GianforteRepublican · House · MT | NEOGNeogen Corporation | Sell (partial) | Joint | Oct 13, 2020 | Nov 9, 2020 | 27 days | $1K-$15K | Filing |
| Donna E. ShalalaDemocrat · House · FL | NEOGNeogen Corporation | Sell | Self | Jun 24, 2019 | Apr 27, 2020 | 308 daysLate | $1K-$15K | Filing |
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.